INTALUS, a U.S.-based advanced materials manufacturer, has secured financing to establish domestic manufacturing facilities and expand hot isostatic pressing (HIP) capacity. The investment will increase U.S. capabilities for densifying metal components, reducing internal defects, and improving material performance for defense, aerospace, energy, and other critical industries.
Rochefort Asset Management, a U.S. national security-focused investment management firm, announced the strategic financing for INTALUS. The funding will support U.S. facilities and machinery for two manufacturing technologies: HIP+ systems and Targeted Phase Infusion (TPI) systems.
The HIP+ systems use heat and pressure to close internal voids and reduce defects in metal components, improving their strength and reliability. The TPI systems incorporate INTALUS’ patented ceramic-metal technology into targeted areas of components to improve resistance to heat, wear, and corrosion.
Together, the technologies are intended to increase domestic capacity for metal component densification and ceramic-metal processing. Potential applications include actuators, fasteners, turbine and reactor components, and equipment used in maritime, space, energy, nuclear, and aerospace applications.
According to the announcement, limited domestic HIP capacity has created processing bottlenecks for U.S. manufacturers, with some companies relying on foreign providers for component densification. The investment is intended to bring additional processing capabilities onshore and serve the U.S. defense industrial base and broader commercial markets.
INTALUS’ technology has previously been used in demanding environments, including Formula One. The financing will help the company transition toward larger-scale domestic production of advanced metal-ceramic components.
Press release is available in its original form here.
